303 related articles for article (PubMed ID: 36293832)
1. LESS-PHARMA Study: Identifying and Deprescribing Potentially Inappropriate Medication in the Elderly Population with Excessive Polypharmacy in Primary Care.
Reus X; Sastre ML; Leiva A; Sánchez B; García-Serra C; Ioakeim-Skoufa I; Vicens C
Int J Environ Res Public Health; 2022 Oct; 19(20):. PubMed ID: 36293832
[TBL] [Abstract][Full Text] [Related]
2. Characteristics of elderly patients with polypharmacy who refuse to participate in an in-hospital deprescribing intervention: a retrospective cross-sectional study.
Komagamine J; Sugawara K; Hagane K
BMC Geriatr; 2018 Apr; 18(1):96. PubMed ID: 29665778
[TBL] [Abstract][Full Text] [Related]
3. Rationalizing prescription via deprescribing in oncology practice.
Raju B; Chaudhary RK; L A; Babu A; Sandeep A; Mateti UV
J Oncol Pharm Pract; 2023 Dec; 29(8):2007-2013. PubMed ID: 37847585
[TBL] [Abstract][Full Text] [Related]
4. Drug Prescribing: Polypharmacy and Deprescribing.
McQuade BM; Campbell A
FP Essent; 2021 Sep; 508():33-40. PubMed ID: 34491710
[TBL] [Abstract][Full Text] [Related]
5. Using Deprescribing Practices and the Screening Tool of Older Persons' Potentially Inappropriate Prescriptions Criteria to Reduce Harm and Preventable Adverse Drug Events in Older Adults.
Earl TR; Katapodis ND; Schneiderman SR; Shoemaker-Hunt SJ
J Patient Saf; 2020 Sep; 16(3S Suppl 1):S23-S35. PubMed ID: 32809998
[TBL] [Abstract][Full Text] [Related]
6. Polypharmacy, the Elderly, and Deprescribing.
Jetha S
Consult Pharm; 2015 Sep; 30(9):527-32. PubMed ID: 26350893
[TBL] [Abstract][Full Text] [Related]
7. Pharmacist-led medication assessment and deprescribing intervention for older adults with cancer and polypharmacy: a pilot study.
Whitman A; DeGregory K; Morris A; Mohile S; Ramsdale E
Support Care Cancer; 2018 Dec; 26(12):4105-4113. PubMed ID: 29869294
[TBL] [Abstract][Full Text] [Related]
8. Potentially inappropriate medication in primary care at the end of life: a mixed-method study.
Pype P; Mertens F; Helewaut F; D'Hulster B; De Sutter A
Acta Clin Belg; 2018 Jun; 73(3):213-219. PubMed ID: 29199905
[TBL] [Abstract][Full Text] [Related]
9. Potentially inappropriate medication and attitudes of older adults towards deprescribing.
Achterhof AB; Rozsnyai Z; Reeve E; Jungo KT; Floriani C; Poortvliet RKE; Rodondi N; Gussekloo J; Streit S
PLoS One; 2020; 15(10):e0240463. PubMed ID: 33104695
[TBL] [Abstract][Full Text] [Related]
10. Potentially inappropriate medication use based on two deprescribing criteria and related factors in patients with terminal cancer: A cross-sectional study.
Kim S; Park S; Yoo SH; Choi KH; Lee JY
J Geriatr Oncol; 2023 Apr; 14(3):101472. PubMed ID: 36931198
[TBL] [Abstract][Full Text] [Related]
11. Effects of an interprofessional Quality Circle-Deprescribing Module (QC-DeMo) in Swiss nursing homes: a randomised controlled trial.
Cateau D; Ballabeni P; Niquille A
BMC Geriatr; 2021 May; 21(1):289. PubMed ID: 33933030
[TBL] [Abstract][Full Text] [Related]
12. Thoughtful Prescribing and Deprescribing.
Pravodelov V
Med Clin North Am; 2020 Sep; 104(5):751-765. PubMed ID: 32773043
[TBL] [Abstract][Full Text] [Related]
13. Deprescribing in palliative patients with cancer: a concise review of tools and guidelines.
van Merendonk LN; Crul M
Support Care Cancer; 2022 Apr; 30(4):2933-2943. PubMed ID: 34617161
[TBL] [Abstract][Full Text] [Related]
14. Combating Polypharmacy Through Deprescribing Potentially Inappropriate Medications.
Chou J; Tong M; Brandt NJ
J Gerontol Nurs; 2019 Jan; 45(1):9-15. PubMed ID: 30653232
[TBL] [Abstract][Full Text] [Related]
15. Deprescribing for older people living in residential aged care facilities: Pharmacist recommendations, doctor acceptance and implementation.
Quek HW; Etherton-Beer C; Page A; McLachlan AJ; Lo SY; Naganathan V; Kearney L; Hilmer SN; Comans T; Mangin D; Lindley RI; Potter K
Arch Gerontol Geriatr; 2023 Apr; 107():104910. PubMed ID: 36565605
[TBL] [Abstract][Full Text] [Related]
16. The potential for deprescribing in a palliative oncology patient population: a cross-sectional study.
van Merendonk LN; Peters BJM; Möhlmann JE; Hunting CB; Kastelijn EA; van den Broek MPH
Eur J Hosp Pharm; 2023 Dec; 31(1):10-15. PubMed ID: 35197277
[TBL] [Abstract][Full Text] [Related]
17. Deprescribing Potentially Inappropriate Preventive Cardiovascular Medication: Barriers and Enablers for Patients and General Practitioners.
Luymes CH; van der Kleij RM; Poortvliet RK; de Ruijter W; Reis R; Numans ME
Ann Pharmacother; 2016 Jun; 50(6):446-54. PubMed ID: 26939589
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of a multi-faceted intervention to deprescribe proton pump inhibitors in primary care: protocol for a population-based, pragmatic, cluster-randomized controlled trial.
Nguyen-Soenen J; Rat C; Gaultier A; Schirr-Bonnans S; Tessier P; Fournier JP
BMC Health Serv Res; 2022 Feb; 22(1):219. PubMed ID: 35177042
[TBL] [Abstract][Full Text] [Related]
19. Deprescribing in multi-morbid older people with polypharmacy: agreement between STOPPFrail explicit criteria and gold standard deprescribing using 100 standardized clinical cases.
Curtin D; Dukelow T; James K; O'Donnell D; O'Mahony D; Gallagher P
Eur J Clin Pharmacol; 2019 Mar; 75(3):427-432. PubMed ID: 30421220
[TBL] [Abstract][Full Text] [Related]
20. Tackling potentially inappropriate prescriptions in older adults: development of deprescribing criteria by consensus from experts in Colombia, Argentina, and Spain.
De Las Salas R; Vaca-González C; Eslava-Schmalbach J; Torres-Espinosa C; Figueras A
BMC Geriatr; 2023 Oct; 23(1):682. PubMed ID: 37864147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
